Skip to Content

Steve is an experienced CEO, with extensive sales and marketing experience over a 38-year history of leading businesses in the pharmaceutical and biologics industry. He was formally CEO of AgriLabs, VP of sales and marketing for Norbrook for the Americas and has held various sales and marketing positions early in his career with Syntex Animal Health. Steve is skilled in go-to-market strategy and implementation of veterinary pharmaceuticals and biologicals for the North American market and has successful history in business development, acquisitions, and business exits.

During his tenure as CEO with AgriLabs, Steve lead the acquisition of Benchmark Biolabs, Antelope Valley Bios, and co-founded VaxLiant. After joining the company in 1995, he was instrumental in making significant investments in R&D to develop new generic pharmaceuticals and novel biological products. He oversaw securing licensing deals that included several domestic and international arrangements, leading to successful introductions of new products to the United States marketplace. AgriLabs developed a patented adjuvant technology that was used in developing DNA vaccines for emerging diseases. In 2017, he led the exit strategy to sell AgriLabs and its subsidiaries to Huvepharma.